Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study https://t.co/TWXjiOjZo1
Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study https://t.co/EydSfZJrRY #jcheminf #cheminformatics #adversedrugs
RT @George_V14: Reviewing proofs for HLA-II screening of @DrugBankDB for HLA-mediated #AdverseDrug reactions. Did you miss our HLA-I proof…
RT @George_V14: Reviewing proofs for HLA-II screening of @DrugBankDB for HLA-mediated #AdverseDrug reactions. Did you miss our HLA-I proof…
Reviewing proofs for HLA-II screening of @DrugBankDB for HLA-mediated #AdverseDrug reactions. Did you miss our HLA-I proof-of-concept study applying Molecular docking to model HLA-B*57:01 ADR? Check it out in the @jcheminf @DFourches #RealTimeChem https
RT @George_V14: Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study https://t.co/LEIU46zvBq #jche…
Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study https://t.co/LEIU46zvBq #jcheminf
Just submitted article No. 2 about modeling #AdverseDrug reactions caused by #HLA Read article No. 1 here https://t.co/LEIU46zvBq
RT @HLA_Alchemist: ADRs triggered by the common HLA-B*57:01 variant: a molecular docking study https://t.co/LEIU46zvBq #jcheminf #Precision…
ADRs triggered by the common HLA-B*57:01 variant: a molecular docking study https://t.co/LEIU46zvBq #jcheminf #PrecisionMedicine
Had a great time attending the @ACSNatlMtg to promote my recent #HLA publication! #ACSSanFran @jcheminf @DFourches https://t.co/LEIU46zvBq
RT @DFourches: Our new study is out this Morning. @HLA_Alchemist https://t.co/tcCriqpDLR
RT @jcheminf: new: "Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study" https://t.co/5Hyonqdtez…
RT @DFourches: Our new study is out this Morning. @HLA_Alchemist https://t.co/tcCriqpDLR
RT @DFourches: Our new study is out this Morning. @HLA_Alchemist https://t.co/tcCriqpDLR
RT @DFourches: Our new study is out this Morning. @HLA_Alchemist https://t.co/tcCriqpDLR
RT @DFourches: Our new study is out this Morning. @HLA_Alchemist https://t.co/tcCriqpDLR
RT @DFourches: Our new study is out this Morning. @HLA_Alchemist https://t.co/tcCriqpDLR
Our new study is out this Morning. @HLA_Alchemist https://t.co/tcCriqpDLR
RT @jcheminf: new: "Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study" https://t.co/5Hyonqdtez…
RT @jcheminf: new: "Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study" https://t.co/5Hyonqdtez…
new: "Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study" https://t.co/5Hyonqdtez https://t.co/7MN7HDkVps